ClinicalTrials.Veeva

Menu

The Test-to-PrEP Study

University of Miami logo

University of Miami

Status

Enrolling

Conditions

HIV Infections

Treatments

Behavioral: Access by Referral
Behavioral: Test-to-PrEP

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06927856
20240478
R01MH138190-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.

Enrollment

320 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria - PrEP Clients (Egos):

  • Stated willingness to provide informed consent.
  • Stated willingness to comply with all study procedures.
  • Stated availability for the duration of the study.
  • Ability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
  • Currently prescribed PrEP by RAPID clinics, including those initiating PrEP on the same day as study enrollment.

Inclusion Criteria for Peers (Alters):

  • Provision of electronic informed consent prior to completion of the Quick Response (QR)-linked survey instruments.

Exclusion Criteria for PrEP Clients (Egos):

  • Inability or refusal to provide informed consent (e.g., cognitive impairment).
  • Unable or unwilling to comply with study procedures per study investigator
  • Inability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
  • Aged 17 years or younger.

Exclusion Criteria for Peers (Alters):

  • Failure to provide electronic informed consent prior to starting QR-linked Alter survey tools.
  • Age 17 years or younger.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

320 participants in 2 patient groups

Test-to-PrEP group
Experimental group
Description:
Participants in this group will receive the Test-to-PrEP intervention for up to 1 year
Treatment:
Behavioral: Test-to-PrEP
Access by Referral group
Experimental group
Description:
Participants in this group will receive the Access by Referral intervention for up to 1 year
Treatment:
Behavioral: Access by Referral

Trial contacts and locations

1

Loading...

Central trial contact

Susanne Doblecki-Lewis, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems